<DOC>
	<DOC>NCT02871596</DOC>
	<brief_summary>The purpose of the study is to determine the effects of both an anthocyanin-rich polyphenol blend and an anthocyanin-rich polyphenol blend combined with a prebiotic blend on fecal microbiota metabolism (assessed by gas chromatograph - mass spectrometry (GC-MS) headspace analysis) and fecal microbiota composition (assessed by next generation sequencing).</brief_summary>
	<brief_title>Effect of a Proprietary Dietary Supplement on Fecal Volatile Organic Compounds</brief_title>
	<detailed_description />
	<criteria>Male or female of any race or ethnicity between 18 to 70 years of age, inclusive; Body mass index (BMI) between 20 32 inclusive; Nonsmoking status; Willing to consume assigned dietary supplements for a total of 6 weeks; Have access to email and a digital camera or camera phone. Age &lt;18 or &gt;70 years; BMI &lt;20 or &gt;32; Uncontrolled hypertension defined as diastolic blood pressure ≥95 mm Hg or systolic blood pressure ≥160 mm Hg; Selfreported presence of atherosclerotic disease and/or cardiopulmonary disease; Renal, hepatic, endocrine, gastrointestinal or other systemic disease; For women, pregnancy, breast feeding or postpartum less than 6 months; Current participation in another research study; Allergy to the components in the dietary supplement (inulin, fructooligosaccharide, blueberries, black currant, rice); History of drug or alcohol abuse; Use of antibiotics within the last 6 months; Use of prebiotics or flavonoidcontaining dietary supplements within the last 30 days; Multiple food allergies or significant food preferences or restrictions that would interfere with diet adherence; Chronic use of overthecounter medication which would interfere with study endpoints including NSAIDS, laxatives and antacids; Participating in or planning to begin a weight loss diet during the study period; Lifestyle or schedule incompatible with the study protocol; Other medical, psychiatric, or behavioral conditions that in the view of the principal investigator may present a safety hazard to the participant or interfere with study participation or the ability to follow the intervention protocol; Use of tobacco products.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>